Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

407 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis.
Mackie SL, Dejaco C, Appenzeller S, Camellino D, Duftner C, Gonzalez-Chiappe S, Mahr A, Mukhtyar C, Reynolds G, de Souza AWS, Brouwer E, Bukhari M, Buttgereit F, Byrne D, Cid MC, Cimmino M, Direskeneli H, Gilbert K, Kermani TA, Khan A, Lanyon P, Luqmani R, Mallen C, Mason JC, Matteson EL, Merkel PA, Mollan S, Neill L, Sullivan EO, Sandovici M, Schmidt WA, Watts R, Whitlock M, Yacyshyn E, Ytterberg S, Dasgupta B. Mackie SL, et al. Among authors: bukhari m. Rheumatology (Oxford). 2020 Mar 1;59(3):e1-e23. doi: 10.1093/rheumatology/kez672. Rheumatology (Oxford). 2020. PMID: 31970405 No abstract available.
BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy.
Deighton C, Hyrich K, Ding T, Ledingham J, Lunt M, Luqmani R, Kiely P, Bukhari M, Abernethy R, Ostor A, Bosworth A, Gadsby K, McKenna F, Finney D, Dixey J; on behalf of BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR. Deighton C, et al. Among authors: bukhari m. Rheumatology (Oxford). 2010 Mar 22. doi: 10.1093/rheumatology/keq006b. Online ahead of print. Rheumatology (Oxford). 2010. PMID: 20308120 No abstract available.
BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy.
Deighton C, Hyrich K, Ding T, Ledingham J, Lunt M, Luqmani R, Kiely P, Bukhari M, Abernethy R, Ostor A, Bosworth A, Gadsby K, McKenna F, Finney D, Dixey J; BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR. Deighton C, et al. Among authors: bukhari m. Rheumatology (Oxford). 2010 Jun;49(6):1197-9. doi: 10.1093/rheumatology/keq006a. Epub 2010 Mar 22. Rheumatology (Oxford). 2010. PMID: 20308121 No abstract available.
BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis.
Bukhari M, Abernethy R, Deighton C, Ding T, Hyrich K, Lunt M, Luqmani R, Kiely P, Bosworth A, Ledingham J, Ostör A, Gadsby K, McKenna F, Finney D, Dixey J; BSR and BHPR Standards, Guidelines and Audit Working Group. Bukhari M, et al. Rheumatology (Oxford). 2011 Dec;50(12):2311-3. doi: 10.1093/rheumatology/ker106a. Epub 2011 May 4. Rheumatology (Oxford). 2011. PMID: 21546351 No abstract available.
New use for tociluzimab in giant cell arteritis.
Bukhari M. Bukhari M. Rheumatology (Oxford). 2017 Dec 1;56(12):2044-2045. doi: 10.1093/rheumatology/kew489. Rheumatology (Oxford). 2017. PMID: 28115597 No abstract available.
407 results